Cytokinetics
CYTK
125 hedge funds and large institutions have $276M invested in Cytokinetics in 2015 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 14 closing their positions.
156% more call options, than puts
Call options by funds: $5.19M | Put options by funds: $2.02M
143% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 14
89% more capital invested
Capital invested by funds: $146M → $276M (+$130M)
19% more funds holding
Funds holding: 105 → 125 (+20)
17% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$13.9M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$10.6M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$7.98M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$4.4M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$4.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$7.14M |
| 2 |
Millennium Management
New York
|
-$4.14M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.49M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.49M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.45M |
CYTK Hedge Fund Activity: Q4 2015 in Review
125 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2015, worth a combined $276M — up 89% from $146M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new CYTK positions and 14 closed out — a net gain of 20 holders — while 42 added to existing stakes and 36 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $13.9M. The largest seller was Morgan Stanley, cutting an estimated $7.14M.
- 125 institutional investors held Cytokinetics (CYTK) as of Q4 2015, up from 105 in Q3 2015.
- Funds reported $276M of Cytokinetics stock for Q4 2015, up 89% quarter-over-quarter.
- 34 funds opened new Cytokinetics positions in Q4 2015 and 14 closed out, a net change of +20 holders.
- The largest Cytokinetics buyer in Q4 2015 was EcoR1 Capital, an estimated $13.9M added.
- The largest Cytokinetics seller in Q4 2015 was Morgan Stanley, an estimated $7.14M sold.
Based on aggregated 13F filings for Q4 2015.